Abstract
Noggin is a secreted antagonist of bone morphogenetic proteins (BMPs) and is involved in the regulation of developmental, homeostatic and neoplastic biological processes. Whilst BMPs have been implicated in many forms of cancer, the effect of noggin on pancreatic cancer remains still poorly understood. Present study aims to examine the role played by Noggin in pancreatic cancer.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
